Investment24 Feb 2026, 06:12 pm
Ind-Swift Laboratories Approves Allotment of 51,00,000 Equity Shares Upon Conversion of Warrants
AI Summary
Ind-Swift Laboratories Ltd. has approved the allotment of 51,00,000 equity shares following the conversion of warrants. The warrants were allotted on August 30, 2024, to Essix Biosciences Limited, a Promoter & Promoter Group entity, at an issue price of Rs. 121/- each on a preferential basis. This allotment has increased the company's paid-up equity share capital to Rs. 86.71 crores. The preferential issue committee meeting was held on February 24, 2026.
Key Highlights
- Ind-Swift Laboratories has approved the allotment of 51,00,000 equity shares upon conversion of warrants.
- The warrants were allotted to Essix Biosciences Limited, a Promoter & Promoter Group entity, at an issue price of Rs. 121/- each.
- This allotment has increased the company's paid-up equity share capital to Rs. 86.71 crores.
- The preferential issue committee meeting was held on February 24, 2026.
- The warrants were allotted on August 30, 2024.